ARDS Market Cap History

Below is a table of the ARDS market cap history going back to 8/14/2018:

Date ARDS Market Cap

Also see: ARDS Shares Outstanding History
and ARDS YTD Return
ARDS Historical Market Cap:
-37.83% CAGR
ARDS Historical Market Cap: +-37.83% CAGR

Mouse over chart for data details
8/14/2018 ...6/2/2023
Aridis Pharmaceuticals is a late-stage biopharmaceutical company focused on the discovery and development of targeted immunotherapy using human monoclonal antibodies (mAbs) to treat infections. Co.'s product candidates include: AR-301, which is a human immunoglobulin 1 (IgG1) mAb targeting the gram-positive bacteria S. aureus alphatoxin; AR-320, which is a human, IgG1 monoclonal antibody targeting S. aureus alpha toxin; AR-501 (Panaecin), which is a spectrum small molecule anti-infective Co. is developing in addition to its targeted mAb product candidates; and AR-701, which is a is a cocktail of human mAbs that are directed at multiple protein epitopes on the SARS-CoV-2 virus. We show 19 historical shares outstanding datapoints in our ARDS shares outstanding history coverage, used to compute ARDS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ARDS market cap history over the course of time is important for investors interested in comparing ARDS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ARDS versus a peer is one thing; comparing ARDS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ARDS can fluctuate over the course of history. With this page we aim to empower investors researching ARDS by allowing them to research the ARDS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ARDS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aridis Pharmaceuticals (ARDS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ARDX Market Cap History
ARMO Market Cap History
ARNA Market Cap History
ARPO Market Cap History
ARQL Market Cap History
ARQT Market Cap History
ARTL Market Cap History
ARVN Market Cap History
ARWR Market Cap History
ASMB Market Cap History
More Healthcare companies »


ARDS Market Cap History | | Copyright © 2017 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.